Background illustration for clinical trials search

Paid Clinical Trials New York City

Discover 4,034 paid clinical trials in New York City, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

for
Obesity, Overweight and/or Obesity, Overweight
Location: New York NY, Rochester NY, Norfolk VA, Hamilton,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07595549

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

for
End Stage Renal Disease (ESRD), Kidney Failure,
Location: New York NY, Newark NJ, The Bronx NY, Sayre PA,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18 - 70+

Code: NCT04671771

Recruiting
Active & Responsive

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for
Relapsed Refractory Multiple Myeloma
Location: New York NY, New Haven CT, Montreal, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07391657

Phase3, Recruiting
Active & Responsive

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: New York NY, Stony Brook NY, Baltimore MD, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06535607

Phase2, Recruiting
Active & Responsive

The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.

for
Glanzmann Thrombasthenia
Location: New York NY
Sponsor: Rockefeller University

Sex: All

Age: 0+

Code: NCT00230165

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

for
Substance Use, HIV Infections
Location: New York NY
Sponsor: Hunter College of City University of New York

Sex: Male

Age: 18 - 55

Code: NCT06307977

Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Richmond VA, Cleveland OH,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase1, Recruiting
Active & Responsive

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for
Ovarian Cancer, Fallopian Tube Cancer
Location: New York NY, Philadelphia PA, Boston MA, St Louis MO,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05287451

Recruiting
Active & Responsive

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: New York NY, Philadelphia PA, Cleveland OH,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT05320198

Phase1, Phase2, Recruiting
Active & Responsive

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

for
Prostate Cancer
Location: New York NY
Sponsor: SpectraCure AB

Sex: Male

Age: 18+

Code: NCT06807359

Phase1, Phase2, Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: New York NY, New Haven CT, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

for
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma,
Location: New York NY, Baltimore MD, Boston MA,
Sponsor: Carl Allen

Sex: All

Age: 0+

Code: NCT04079179

Phase2, Recruiting
Active & Responsive

Study of REM-422 in Patients With AML or Higher Risk MDS

for
Myelodysplastic Syndromes,
Location: New York NY, Boston MA, Tampa FL, Houston TX, Duarte CA
Sponsor: Remix Therapeutics

Sex: All

Age: 18+

Code: NCT06297941

Phase1, Recruiting
Active & Responsive

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: New York NY, Columbus OH, St Louis MO, Los Angeles CA,
Sponsor: Kamau Therapeutics

Sex: All

Age: 12 - 50

Code: NCT04819841

Phase1, Phase2, Recruiting
Active & Responsive

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

for
Metastatic Hepatocellular Carcinoma,
Location: New York NY, Pittsburgh PA, Zion IL, Nashville TN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06427941

Phase1, Phase2, Recruiting
Active & Responsive

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: New York NY, Hackensack NJ, Queens NY, Morristown NJ,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 21

Code: NCT05183035

Phase3, Recruiting
Active & Responsive

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

for
Myelofibrosis (PMF),
Location: New York NY, Buffalo NY, Cleveland OH, Winston-Salem NC,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT05835466

Phase2, Recruiting
Active & Responsive

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

for
Hematologic Malignancy, GvHD, GVHD,Acute, GVHD, Chronic,
Location: New York NY, Boston MA, Minneapolis MN, Seattle WA,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18+

Code: NCT06462365

Phase1, Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: New York NY, The Bronx NY, Uniondale NY, Montvale NJ,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase2, Recruiting
Active & Responsive

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

for
Urothelial Carcinoma
Location: New York NY, Pittsburgh PA, Toronto, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05562830

Phase1, Phase2, Recruiting

New York City stands out as a location known for a diverse array of clinical trials, thanks to its extensive healthcare network and renowned medical research institutions. Leading centers such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, Mount Sinai Health System, and Weill Cornell Medicine are at the forefront of pioneering studies across various fields. The city's rich combination of cutting-edge research facilities and a diverse population enhances the scope and impact of clinical trials conducted here.

Why choose New York City for clinical trials?

New York City is an exceptional choice for participating in clinical trials, renowned for its innovative research environment and strong emphasis on groundbreaking medical advancements, with prestigious institutions such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, and Mount Sinai Health System at the forefront.

By participating in a clinical trial in New York City, you not only gain early access to cutting-edge treatments but also contribute to significant medical research that could shape future healthcare practices.

Common conditions studied in New York City

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New York City